{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:52Z","timestamp":1786120372809,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Previous studies have shown that selective decontamination of the digestive tract can reduce the incidence and mortality of ventilator-associated pneumonia (VAP) in mechanically ventilated patients. However, the prophylactic role of IV antibacterials, one of its essential components, remains unclear. Therefore, this study aims to evaluate the efficacy and safety of systemic prophylactic use of antibacterials in mechanically ventilated patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources:<\/jats:title>\n                    <jats:p>We systematically searched PubMed, Embase, and The Cochrane Library from inception to November 30, 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Selection:<\/jats:title>\n                    <jats:p>Randomized controlled trials (RCTs) evaluating prophylactic use of systemic antibacterials in mechanically ventilated patients in the ICUs were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Extraction:<\/jats:title>\n                    <jats:p>Two researchers independently conducted literature screening, data extraction, and quality assessment. Meta-analysis was performed using RevMan 5.4, and the quality of the evidence was evaluated using the recommended Grading of Recommendations, Assessment, Development, and Evaluation method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Synthesis:<\/jats:title>\n                    <jats:p>Eleven RCTs with 5562 patients were included. Meta-analysis results showed that the systemic prophylactic use of antibacterials probably reduces the incidence of VAP (relative risk [RR], 0.65; 95% CI, 0.55\u20130.77; moderate certainty) and the incidence of early VAP (RR, 0.52; 95% CI, 0.41\u20130.66; moderate certainty), but probably does not reduce in-hospital mortality (RR, 0.85; 95% CI, 0.68\u20131.06; moderate certainty) or duration of mechanical ventilation (mean difference [MD], \u20130.32; 95% CI, \u20130.79 to 0.16; moderate certainty), and may not reduce length of hospital stay (MD, \u20131.56; 95% CI, \u20135.15 to 2.02; low certainty). Subgroup analyses suggested that systemic prophylactic antibacterials probably reduces VAP in brain injury patients. No increased risk of drug resistance and adverse events was observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The systemic prophylactic antibacterials probably reduces early VAP and overall VAP incidence in mechanically ventilated patients, but probably does not reduce in-hospital mortality. Subgroup analyses suggested potential benefits in brain injury patients. Given incomplete safety reporting, future research should include comprehensive resistance surveillance and cost-effectiveness analyses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000007183","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:00:32Z","timestamp":1780322432000},"page":"2102-2111","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and Safety of Systemic Prophylactic Antibacterials in Mechanically Ventilated Patients: Systematic Review and Meta-Analysis"],"prefix":"10.1097","volume":"54","author":[{"given":"Qiuying","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Peking University Third Hospital, Beijing, China."},{"name":"Department of Pharmacy, The 988th Hospital of the Joint Logistics Support Force, Zhengzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Peking University Third Hospital, Beijing, China."},{"name":"Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinggang","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Peking University Third Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The 988th Hospital of the Joint Logistics Support Force, Zhengzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suodi","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Peking University Third Hospital, Beijing, China."},{"name":"Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"R1-20260806","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1007\/s00134-015-3909-8","article-title":"What\u2019s new in ventilator-associated pneumonia?","volume":"41","author":"Rello","year":"2015","journal-title":"Intensive Care Med"},{"key":"R2-20260806","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society.","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R3-20260806","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/MCP.0000000000000151","article-title":"Ventilator associated pneumonia in the ICU: Where has it gone?","volume":"21","author":"Guillamet","year":"2015","journal-title":"Curr Opin Pulm Med"},{"key":"R4-20260806","first-page":"CD000022","article-title":"Topical antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving mechanical ventilation.","volume":"1","author":"Minozzi","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"R5-20260806","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.ajic.2021.04.077","article-title":"International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2013-2018, adult and pediatric units, device-associated module.","volume":"49","author":"Rosenthal","year":"2021","journal-title":"Am J Infect Control"},{"issue":"Suppl_2","key":"R6-20260806","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1093\/cid\/ciy692","article-title":"The current epidemiological landscape of ventilator-associated pneumonia in the intensive care unit: A multicenter prospective observational study in China.","volume":"67","author":"Xie","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R7-20260806","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S1473-3099(13)70081-1","article-title":"Attributable mortality of ventilator-associated pneumonia: A meta-analysis of individual patient data from randomised prevention studies.","volume":"13","author":"Melsen","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"R8-20260806","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1001\/jamainternmed.2013.9763","article-title":"Health care-associated infections: A meta-analysis of costs and financial impact on the US health care system.","volume":"173","author":"Zimlichman","year":"2013","journal-title":"JAMA Intern Med"},{"key":"R9-20260806","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1183\/09031936.00048507","article-title":"Evidence on measures for the prevention of ventilator-associated pneumonia.","volume":"30","author":"Lorente","year":"2007","journal-title":"Eur Respir J"},{"key":"R10-20260806","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1086\/653060","article-title":"Mortality, attributable mortality, and clinical events as end points for clinical trials of ventilator-associated pneumonia and hospital-acquired pneumonia.","volume":"51","author":"Muscedere","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R11-20260806","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S2213-2600(14)70144-4","article-title":"Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): A double-blind, multicentre phase 3, randomised placebo-controlled trial.","volume":"2","author":"Asehnoune","year":"2014","journal-title":"Lancet Respir Med"},{"key":"R12-20260806","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/01.CCM.0000063087.93157.06","article-title":"Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.","volume":"31","author":"Warren","year":"2003","journal-title":"Crit Care Med"},{"key":"R13-20260806","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/664049","article-title":"Economic impact of ventilator-associated pneumonia in a large matched cohort.","volume":"33","author":"Kollef","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R14-20260806","doi-asserted-by":"crossref","first-page":"1700582","DOI":"10.1183\/13993003.00582-2017","article-title":"International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)\/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociaci\u00f3n Latinoamericana del T\u00f3rax (ALAT).","volume":"50","author":"Torres","year":"2017","journal-title":"Eur Respir J"},{"key":"R15-20260806","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1001\/jama.2022.19709","article-title":"Association between selective decontamination of the digestive tract and in-hospital mortality in intensive care unit patients receiving mechanical ventilation: A systematic review and meta-analysis.","volume":"328","author":"Hammond","year":"2022","journal-title":"JAMA"},{"key":"R16-20260806","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.hrtlng.2013.09.002","article-title":"Implementing selective digestive tract decontamination in the intensive care unit: A qualitative analysis of nurse-identified considerations.","volume":"43","author":"Marshall","year":"2014","journal-title":"Heart Lung"},{"key":"R17-20260806","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s00134-010-1826-4","article-title":"Impact of digestive and oropharyngeal decontamination on the intestinal microbiota in ICU patients.","volume":"36","author":"Benus","year":"2010","journal-title":"Intensive Care Med"},{"key":"R20-20260806","first-page":"737","article-title":"Risk bias assessment tool RoB2 (revised version 2019) for randomized controlled trial: An interpretation.","volume":"21","author":"Liu","year":"2021","journal-title":"Chin J Evid-based Med"},{"key":"R21-20260806","first-page":"437","article-title":"GRADE guidelines: 1. Introduction to GRADE evidence profiles and summary of findings tables.","volume":"11","author":"Guyatt","year":"2011","journal-title":"Chin J Evid-based Med"},{"key":"R22-20260806","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1164\/ajrccm.155.5.9154884","article-title":"Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma.","volume":"155","author":"Sirvent","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"R23-20260806","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00134-005-2585-5","article-title":"Antibiotic prophylaxis of early onset pneumonia in critically ill comatose patients. A randomized study.","volume":"31","author":"Acquarolo","year":"2005","journal-title":"Intensive Care Med"},{"key":"R24-20260806","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jhin.2018.08.017","article-title":"Efficacy of antibiotic prophylaxis against ventilator-associated pneumonia.","volume":"101","author":"Mirtalaei","year":"2019","journal-title":"J Hosp Infect"},{"key":"R25-20260806","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1056\/NEJMoa1812379","article-title":"Prevention of early ventilator-associated pneumonia after cardiac arrest.","volume":"381","author":"Francois","year":"2019","journal-title":"N Engl J Med"},{"key":"R26-20260806","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00134-013-2997-6","article-title":"Pre-emptive broad-spectrum treatment for ventilator-associated pneumonia in high-risk patients.","volume":"39","author":"Bouza","year":"2013","journal-title":"Intensive Care Med"},{"key":"R27-20260806","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s00134-012-2559-3","article-title":"Azithromycin to prevent Pseudomonas aeruginosa ventilator-associated pneumonia by inhibition of quorum sensing: A randomized controlled trial.","volume":"38","author":"Delden","year":"2012","journal-title":"Intensive Care Med"},{"key":"R28-20260806","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00003246-198906000-00003","article-title":"Prevention of pneumonia in an intensive care unit: A randomized multicenter clinical trial.","volume":"6","author":"Mandelli","year":"1989","journal-title":"Crit Care Med"},{"key":"R29-20260806","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa0800394","article-title":"Decontamination of the digestive tract and oropharynx in ICU patients.","volume":"360","author":"DeSmet","year":"2009","journal-title":"N Engl J Med"},{"key":"R30-20260806","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.resuscitation.2016.11.025","article-title":"Prophylactic versus clinically-driven antibiotics in comatose survivors of out-of-hospital cardiac arrest\u2014a randomized pilot study.","volume":"111","author":"Ribaric","year":"2017","journal-title":"Resuscitation"},{"key":"R31-20260806","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S2213-2600(23)00471-X","article-title":"Ceftriaxone to prevent early ventilator-associated pneumonia in patients with acute brain injury: A multicentre, randomised, double-blind, placebo-controlled, assessor-masked superiority trial.","volume":"12","author":"Dahyot-Fizelier","year":"2024","journal-title":"Lancet Respir Med"},{"key":"R32-20260806","first-page":"1","article-title":"Ceftriaxone to prevent early-onset pneumonia in comatose patients following out-of-hospital cardiac arrest: A pilot randomized controlled trial and resistome assessment (PROTECT).","volume":"8","author":"Gagnon","year":"2025","journal-title":"Chest"},{"key":"R33-20260806","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ajic.2005.04.246","article-title":"Systematic review of economic analyses of health care-associated infections.","volume":"33","author":"Stone","year":"2005","journal-title":"Am J Infect Control"},{"key":"R34-20260806","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1186\/cc11346","article-title":"Number needed to treat and cost-effectiveness in the prevention of ventilator-associated pneumonia.","volume":"16","author":"Wyncoll","year":"2012","journal-title":"Crit Care"},{"key":"R35-20260806","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.chest.2024.10.031","article-title":"Prophylactic antibiotics in adults with acute brain injury who are invasively ventilated in the ICU: A systematic review and meta-analysis.","volume":"167","author":"Hadley-Brown","year":"2025","journal-title":"Chest"},{"key":"R36-20260806","doi-asserted-by":"crossref","first-page":"e1269","DOI":"10.1097\/CCM.0000000000006654","article-title":"Associations between prophylactic IV antibiotics and outcomes in patients with acute severe brain injury who require mechanical ventilation: Systematic review and meta-analysis.","volume":"53","author":"Ehrenzeller","year":"2025","journal-title":"Crit Care Med"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:38:20Z","timestamp":1786048700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000007183","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}